Cara Therapeutics Inc (NASDAQ:CARA)
| 12.79 Delayed Data As of 1:00pm ET |  -0.55 / -4.12%Today’s Change | 11.22 Today|||52-Week Range 29.65 | -15.47% Year-to-Date |
Latest CARA News | Press Releases
No recent news for Cara Therapeutics Inc.
Today’s Trading
| Previous close | 13.34 |
| Today’s open | 13.24 |
| Day’s range | 12.50 - 13.24 |
| Volume | 13,950 |
| Average volume (3 months) | 1,347,034 |
| Market cap | $758.6M |
Data as of 1:00pm ET, 11/26/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1,030.16% |
| Earnings growth (next 5 years) | -66.83% |
| Revenue growth (last year) | +579.28% |
| P/E ratio | 21.7 |
| Price/Sales | 5.37 |
| Price/Book | 2.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VBIVVBI Vaccines Inc | -0.08 | -2.80% |
| BLUEbluebird bio Inc | -0.24 | -2.23% |
| ADAPAdaptimmune Therapeu... | -0.20 | -4.67% |
| BTAIBioXcel Therapeutics... | -1.30 | -5.45% |
Data as of 1:58pm ET, 11/26/2021
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $135.1M |
| Annual profit (last year) | $8.4M |
| Net profit margin | 6.23% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stamford, Connecticut |
Forecasts
